Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 Nov;107(3):679–683. doi: 10.1111/j.1476-5381.1992.tb14506.x

In vitro effect of oestradiol on thymidine uptake in pulmonary vascular smooth muscle cell: role of the endothelium.

M Y Farhat 1, R Vargas 1, B Dingaan 1, P W Ramwell 1
PMCID: PMC1907765  PMID: 1472966

Abstract

1. The effect of different concentrations of oestradiol-17 beta (3-300 nM) on [3H]-thymidine uptake was studied in segments from canine pulmonary artery, and cultures of rat pulmonary vascular smooth muscle cells (VSMC). 2. Incubation with oestradiol-17 beta for 24 h, potentiated in a concentration-dependent manner [3H]-thymidine uptake in VSMC cultures. 3. Oestradiol-17 beta potentiated thymidine uptake by pulmonary arterial segments but only when the endothelium had been removed. Autoradiography showed dense incorporation of radioactive thymidine in the vascular smooth muscle cells of the media. 4. The non-steroidal oestrogen, stilboestrol (300 nM), also significantly potentiated [3H]-thymidine uptake, in both VSMC cultures and pulmonary artery segments. Testosterone was ineffective at a similar concentration. 5. Pre-incubation of the pulmonary VSMC with the anti-oestrogen tamoxifen (1 microM) antagonized the potentiating effect of oestradiol-17 beta on [3H]-thymidine incorporation. The effect of tamoxifen was less pronounced in pulmonary arterial segments. 6. These data suggest that oestrogen may promote proliferation of pulmonary VSMC. Endothelial injury or dysfunction may be an important factor in the expression of the oestrogenic effect. 7. We speculate that plasma oestrogen may be a contributing factor to the proliferative lesion observed in certain forms of pulmonary vascular injury in women.

Full text

PDF
679

Images in this article

681Figure 3
on p.681

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams D. J., Edwards D. P., McGuire W. L. Estrogen regulation of specific messinger RNA's in human breast cancer cells. Biochem Biophys Res Commun. 1980 Dec 31;97(4):1354–1361. doi: 10.1016/s0006-291x(80)80016-7. [DOI] [PubMed] [Google Scholar]
  2. Chalbos D., Vignon F., Keydar I., Rochefort H. Estrogens stimulate cell proliferation and induce secretory proteins in a human breast cancer cell line (T47D). J Clin Endocrinol Metab. 1982 Aug;55(2):276–283. doi: 10.1210/jcem-55-2-276. [DOI] [PubMed] [Google Scholar]
  3. Cheng L. P., Kuwahara M., Jacobsson J., Foegh M. L. Inhibition of myointimal hyperplasia and macrophage infiltration by estradiol in aorta allografts. Transplantation. 1991 Dec;52(6):967–972. doi: 10.1097/00007890-199112000-00006. [DOI] [PubMed] [Google Scholar]
  4. Clarkson T. B., Shively C. A., Morgan T. M., Koritnik D. R., Adams M. R., Kaplan J. R. Oral contraceptives and coronary artery atherosclerosis of cynomolgus monkeys. Obstet Gynecol. 1990 Feb;75(2):217–222. [PubMed] [Google Scholar]
  5. Cohen D. R., Curran T. The structure and function of the fos proto-oncogene. Crit Rev Oncog. 1989;1(1):65–88. [PubMed] [Google Scholar]
  6. Davidson N. E., Lippman M. E. The role of estrogens in growth regulation of breast cancer. Crit Rev Oncog. 1989;1(1):89–111. [PubMed] [Google Scholar]
  7. Dickson R. B., Huff K. K., Spencer E. M., Lippman M. E. Induction of epidermal growth factor-related polypeptides by 17 beta-estradiol in MCF-7 human breast cancer cells. Endocrinology. 1986 Jan;118(1):138–142. doi: 10.1210/endo-118-1-138. [DOI] [PubMed] [Google Scholar]
  8. Fischer-Dzoga K., Wissler R. W., Vesselinovitch D. The effect of estradiol on the proliferation of rabbit aortic medial tissue culture cells induced by hyperlipemic serum. Exp Mol Pathol. 1983 Dec;39(3):355–363. doi: 10.1016/0014-4800(83)90064-3. [DOI] [PubMed] [Google Scholar]
  9. Foegh M. L., Khirabadi B. S., Nakanishi T., Vargas R., Ramwell P. W. Estradiol protects against experimental cardiac transplant atherosclerosis. Transplant Proc. 1987 Aug;19(4 Suppl 5):90–95. [PubMed] [Google Scholar]
  10. Francavilla A., Polimeno L., DiLeo A., Barone M., Ove P., Coetzee M., Eagon P., Makowka L., Ambrosino G., Mazzaferro V. The effect of estrogen and tamoxifen on hepatocyte proliferation in vivo and in vitro. Hepatology. 1989 Apr;9(4):614–620. doi: 10.1002/hep.1840090417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Furchgott R. F., Zawadzki J. V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980 Nov 27;288(5789):373–376. doi: 10.1038/288373a0. [DOI] [PubMed] [Google Scholar]
  12. Garg U. C., Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989 May;83(5):1774–1777. doi: 10.1172/JCI114081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Harder D. R., Coulson P. B. Estrogen receptors and effects of estrogen on membrane electrical properties of coronary vascular smooth muscle. J Cell Physiol. 1979 Aug;100(2):375–382. doi: 10.1002/jcp.1041000218. [DOI] [PubMed] [Google Scholar]
  14. Heath D., Smith P., Gosney J., Mulcahy D., Fox K., Yacoub M., Harris P. The pathology of the early and late stages of primary pulmonary hypertension. Br Heart J. 1987 Sep;58(3):204–213. doi: 10.1136/hrt.58.3.204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Jordan V. C. Biochemical pharmacology of antiestrogen action. Pharmacol Rev. 1984 Dec;36(4):245–276. [PubMed] [Google Scholar]
  16. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  17. Lin A. L., McGill H. C., Jr, Shain S. A. Hormone receptors of the baboon cardiovascular system. Biochemical characterization of aortic and myocardial cytoplasmic progesterone receptors. Circ Res. 1982 May;50(5):610–616. doi: 10.1161/01.res.50.5.610. [DOI] [PubMed] [Google Scholar]
  18. Lippman M., Bolan G., Huff K. The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res. 1976 Dec;36(12):4595–4601. [PubMed] [Google Scholar]
  19. McGuire W. L., Dressler L. G., Sledge G. W., Jr, Ramzy I., Ciocca D. R. An estrogen-regulated protein in normal and malignant endometrium. J Steroid Biochem. 1986 Jan;24(1):155–159. doi: 10.1016/0022-4731(86)90045-2. [DOI] [PubMed] [Google Scholar]
  20. Nishizawa Y., Sato B., Miyashita Y., Tsukada S., Hirose T., Kishimoto S., Matsumoto K. Autocrine regulation of cell proliferation by estradiol and hydroxytamoxifen of transformed mouse Leydig cells in serum-free culture. Endocrinology. 1988 Jan;122(1):227–235. doi: 10.1210/endo-122-1-227. [DOI] [PubMed] [Google Scholar]
  21. Papa M., Mezzogiorno V., Bresciani F., Weisz A. Estrogen induces c-fos expression specifically in the luminal and glandular epithelia of adult rat uterus. Biochem Biophys Res Commun. 1991 Mar 15;175(2):480–485. doi: 10.1016/0006-291x(91)91589-5. [DOI] [PubMed] [Google Scholar]
  22. Rich S., Dantzker D. R., Ayres S. M., Bergofsky E. H., Brundage B. H., Detre K. M., Fishman A. P., Goldring R. M., Groves B. M., Koerner S. K. Primary pulmonary hypertension. A national prospective study. Ann Intern Med. 1987 Aug;107(2):216–223. doi: 10.7326/0003-4819-107-2-216. [DOI] [PubMed] [Google Scholar]
  23. Savajiyani R., Benchimol A., Desser K. B. Primary pulmonary hypertension. A review. Ariz Med. 1981 Dec;38(12):898–901. [PubMed] [Google Scholar]
  24. Smith P., Moosavi H., Winson M., Heath D. The influence of age and sex on the response of the right ventricle, pulmonary vasculature and carotid bodies to hypoxia in rats. J Pathol. 1974 Jan;112(1):11–18. doi: 10.1002/path.1711120104. [DOI] [PubMed] [Google Scholar]
  25. Soto A. M., Sonnenschein C. The role of estrogens on the proliferation of human breast tumor cells (MCF-7). J Steroid Biochem. 1985 Jul;23(1):87–94. doi: 10.1016/0022-4731(85)90265-1. [DOI] [PubMed] [Google Scholar]
  26. Stampfer M. J., Colditz G. A., Willett W. C., Manson J. E., Rosner B., Speizer F. E., Hennekens C. H. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N Engl J Med. 1991 Sep 12;325(11):756–762. doi: 10.1056/NEJM199109123251102. [DOI] [PubMed] [Google Scholar]
  27. Vignon F., Capony F., Chambon M., Freiss G., Garcia M., Rochefort H. Autocrine growth stimulation of the MCF 7 breast cancer cells by the estrogen-regulated 52 K protein. Endocrinology. 1986 Apr;118(4):1537–1545. doi: 10.1210/endo-118-4-1537. [DOI] [PubMed] [Google Scholar]
  28. Zidek T., Steurer G., Fitscha P., Sinzinger H. Beneficial effect of prostaglandin I2 on smooth muscle cell proliferation. Prog Clin Biol Res. 1987;242:357–363. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES